Are We Making Progress in Valuing Health and Longevity in Regulatory Analysis?
Although agencies have made strides concerning values for mortality risk reductions, more research is needed on these values.
Updating the Benefits of Preventing Acute Illness
New research finds higher values for protection against risks of short-term foodborne illness.
New Recommendations for Valuing Mortality Risk Reductions
EPA’s Science Advisory Board offers recommendations to improve cost-benefit analysis.